Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Treasury Shares (2016 - 2026)

Pharma-Bio Serv filings provide 12 years of Treasury Shares readings, the most recent being $580967.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 6.05% to $580967.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $580967.0, a 6.05% increase, with the full-year FY2025 number at $579286.0, up 5.74% from a year prior.
  • Treasury Shares hit $616780.0 in Q1 2026 for Pharma-Bio Serv, up from $613680.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $616780.0 in Q1 2026 to a low of $484329.0 in Q1 2022.
  • Median Treasury Shares over the past 5 years was $556529.0 (2024), compared with a mean of $552146.9.
  • Biggest five-year swings in Treasury Shares: grew 26.78% in 2022 and later increased 0.75% in 2025.
  • Pharma-Bio Serv's Treasury Shares stood at $502236.0 in 2022, then grew by 6.84% to $536580.0 in 2023, then grew by 2.1% to $547843.0 in 2024, then rose by 5.74% to $579286.0 in 2025, then grew by 0.29% to $580967.0 in 2026.
  • The last three reported values for Treasury Shares were $580967.0 (Q1 2026), $579286.0 (Q4 2025), and $570084.0 (Q3 2025) per Business Quant data.